Apeiron Capital Investment in an 8-K said it called off a merger with GIO World Health and disclosed plans to rdeeem shares and dissolve, effective today. The $250 million deal was announced in March with an anticipated closing in the second half of the year.
No reason was given for the termination.
Apeiron raised $150 million in a November 2021 IPO.
GIO World Health is a stem cell-based life science company with plans to distribute selective products and services globally. Read more.
